✦ LIBER ✦

Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension

✍ Scribed by Seino, Yutaka; Fujita, Tetsuya; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of alogliptin added

✍ K. Kaku; T. Itayasu; S. Hiroi; M. Hirayama; Y. Seino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Efficacy and safety of alogliptin added

✍ Y. Seino; Y. Miyata; S. Hiroi; M. Hirayama; K. Kaku 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Efficacy and safety of alogliptin added

✍ Seino, Yutaka; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 270 KB

Efficacy and safety of alogliptin in Jap

✍ Seino, Yutaka; Fujita, Tetsuya; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 487 KB

Efficacy and safety of sitagliptin monot

✍ Y. Iwamoto; N. Tajima; T. Kadowaki; K. Nonaka; T. Taniguchi; M. Nishii; J. C. Ar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

Linagliptin monotherapy provides superio

✍ R. Kawamori; N. Inagaki; E. Araki; H. Watada; N. Hayashi; Y. Horie; A. Sarashina 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB